Soluble human leukocyte antigens, interleukin-6, and interferon-γ during pregnancy

American Journal of Reproductive Immunology

Volumn 38, Issue 4, 1997, Pages 256-262

  Russwurm, G P ^a   Mackler, A M ^a   Fagoaga, O R ^a   Brown III, W S ^a   Sakala, E P ^a   Yellon, S M ^a   Nehlsen Cannarella, S L ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti paternal IgG; Fetal immunity; Immunosuppression; sHLA

Indexed keywords

CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; LEUKOCYTE ANTIGEN;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MATERNAL BLOOD; NORMAL HUMAN; PLACENTA; PREGNANCY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

EID: 0030779930     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00512.x     Document Type: Article

References (51)

1. Reed E, Beer AE, Hutcherson H, King DW, Suciu-Foca N: The alloantibody response of pregnant women and its suppression by soluble HLA antigens and anti-idiotypic antibodies. J Reprod Immunol 1991; 20:115-128.
2. Regan L, Braude PR, Hill DP: A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6:294-298.
3. Van Rood JJ, Van Leuven A, Eernisse JG: Leucocyte antibodies in sera from pregnant women. Nature 1958; 181:1735-1736.
4. Ferreira A, Garcia-Rodriguez MC, Omenaca F, Jimenez A, Villar LM, Gonzalez-Porque P, Fontan G: Soluble class I histocompatibility antigens (s-HLA) and beta 2-microglobulin at delivery. Clin Exp Immunol 1991; 84:167-169.
5. Christiansen OB: A fresh look at the and treatments of recurrent miscarriage, especially its immunological aspects. Hum Reprod Update 1996; 2:271-293.
6. Webb BJ, Bochan MR, Montel A, Padilla LM, Brahmi Z: The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum. Cell Immunol 1994; 159:246-261.
7. Claus R, Hausmann S, Zavazava N, Walzel H, Schulze HA, Kohler H, Friemel H, Muller Ruchholtz W: In vitro effects of solubilized HLA-DR-role in immunoregulation? Cell Immunol 1994; 155:476-485.
8. Buelow R, Burlingham WJ, Clayberger C: Immunomodulation by soluble HLA class I. Transplantation 1995; 59:649-654.
9. Mathew JM, Marsh JW, Susskind B, Mohanakumar T: Analysis of T cell responses in liver allograft recipients. Evidence for deletion of donor-specific cytotoxic T cells in the peripheral circulation. J Clin Invest 1993; 91:900-906.
10. Kamada N, Wight DG: Antigen-specific immunosuppression induced by liver transplantation in the rat. Transplantation 1984; 34:217-221.
11. Lu L, Woo J, Rao AS, Li Y, Watkins SC, Qian S, Starzl TE, Demetris AJ, Thomson AW: Propagation of dendritic cell progenitors from normal mouse liver granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179:1823-1834.
12. Priestley CA, Dalchau R, Sawyer GJ, Fabre JW: A detailed analysis of the potential of water-soluble classical class I MHC molecule for the suppression of kidney allograft rejection and in vitro cytotoxic T cell responses. Transplantation 1989; 48:1031-1038.
13. Sumimoto R, Kamada N: Evidence that soluble class I antigen in donor serum includes the suppression of heart allograft rejection in rats. Immunol Lett 1990; 26:81-84.
14. Sumimoto R, Kamada N: Specific suppression of allograft rejection by soluble I antigen and complexes with monoclonal antibody. Transplantation 1990; 50:678-682.
15. Foster S, Wood KJ, Morris PJ: Comparison of the effect of protein micelles containing purified class I MHC antigen and a cytosolic preparation containing water soluble I molecules on rat allograft survival. Transplant Proc 1989; 21:375-376.
16. Foster S, Wood KJ, Morris PJ: The effectiveness of pretreatment with soluble or membrane-bound donor class I major histocompatibility complex antigens in the induction of unresponsiveness to a subsequent rat renal allograft. Transplantation 1992; 53:1322-1328.
17. Shimura T, Hagihara M, Yamamoto K, Takebe K, Munkhbat B, Ogoshi K, Mitomi T, Nagamachi Y, Tsuji K: Quantification of serum-soluble HLA class I antigens in patients with gastric cancer. Hum Immunol 1994; 40:183-186.
18. Tartter PI: The association of perioperative blood transfusion with colorectal cancer recurrence. Am Surg 1991; 58:838-842.
19. Nelson JL, Huges KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA: Maternal-fetal disparity in HLA class II alloantigens and the pregnancy induced amelioration of rheumatoid arthritis. N Engl J Med 1993; 329:500-501.
20. Nicolle MW, Nag B, Sharma SD, Willcox N, Vincent A, Ferguson DJ, Newsom-Davis J: Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes. J Clin Invest 1994; 93:1361-1369.
21. Natali PG, Bigotti A, Viora M, Manfredi D, Ferrone S: Distribution of human I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984; 44:4679-4687.
22. Zavazava N, Wobst B, Ferstl R, Muller Ruchholtz W: Soluble MHC class I molecules in human body fluids. J Clin Lab Anal 1994; 8:432-436.
23. Fujii T, Ishitani A, Geraghty DE: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 1994; 153:5516-5524.
24. Pickl WF, Majdic O, Fae I, Reuschel R, Holter W, Knapp W: The soluble pool of beta 2-microglobulin free HLA class I alpha-chains. Qualitative and quantitative characterization. J Immunol 1993; 151:2613-2622.
25. Kubens BS, Passler M, Grosse-Wilde H: Segregation study of the soluble 39-kD HLA class I heavy chain. Hum Immunol 1994; 40:247-252.
26. He X, Le J: Alternative splicing of HLA class I transcripts induced by IFN-gamma and TNF in fibroblasts: Release of soluble HLA class I heavy chain and an associate protein. Cell Immunol 1995; 162:159-168.
27. Le J, Hua JC: Production of soluble HLA-class-I molecules by IFN-gamma-induced colon-adenocarcinoma cells. Int J Cancer 1995; 50:576-581.
28. Benacerraf B: Role of MHC gene products in immune regulation. Science 1981; 212:1229-1238.
29. Kaufman JF, Auffray C, Korman AJ: The class II molecules of the human and murine major histocompatibility complex. Cell 1984; 36:1-13.
30. Jendro M, Goronzy JJ, Weyand CM: Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 1991; 8:289-296.
31. Claus R, Werner H, Schulze HA, Walzel H, Friemel H: Are soluble monocyte-derived HLA class II molecules candidate for immunosuppressive activity? Immunol Lett 1990; 26:203-210.
32. Kamada N: Transplantation tolerance and immunosuppression following liver grafting in rats, Immunol Today 1985; 6:336-338.
33. Davies HS, Pollard SG, Calne RY: Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989; 47:524-527.
34. Davis H, Kamada N, Roser BJ: Clonal deletion of all reactive cells. Mechanism of donor-specific unresponsiveness induced by liver grafting. Transplant Proc 1983; 25:831-834.
35. Sharma SD, Nag B, Su XM, Green D, Spack E, Clark BR, Sriram S: Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes. Proc Natl Acad Sci USA 1991; 88:11465-11469.
36. Opsjohn SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R: Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993; 169:397-404.
37. Tanabe M, Sekimata M, Ferrone S, Takiguchi M: Structural and functional analysis of monomorphic determinants recognized by monoclonal antibodies reacting with the HLA class I α3 domain. J Immunol 1992; 148:3203-3209.
38. Westhoff U, Thinnes FP, Gotz H, Grosse-Wilde H: Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang 1991; 61:106-110.
39. Nehlsen-Cannarella SL, Chang L: Immunology and organ transplantation in the neonate and young infant. Crit Care Nursing Clinics N Am 1992; 4:179-191.
40. Bouma GJ, van Caubergh P, van Bree, SPMJ, Castelli-Visser RMC, Witvliet MD, van der Meer-Prins EMW, van Rood JJ, Claas FHJ: Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation 1996; 62:672-678.
41. Desai RG, Creger WP: Maternofetal passage of leukocytes and platelets in man. Blood 1963; 21:665-673.
42. Zarou DM, Lichtman HC, Hellman, LM: The transmission of chromium-51 tagged maternal erythrocytes from mother to fetus. Am J Obstet Gynecol 1964; 88:565-571.
43. Pollack MS, Kapoor N, Sorell M, Kim SJ, Christiansen FT, Silver KM, Dupont B, O'Reilly RJ: DR-positive maternal engrafted T cells in a severe combined immunodeficiency patient without graft-versus-host disease. Transplantation 1980; 30:331-334.
44. Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ: Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency. N Engl J Med 1982; 307:662-666.
45. Flomenberg N, Dupont B, O'Reilly RJ, Hayward A, Pollack MS: The use of T cell culture techniques to establish the presence of an intrauterine derived maternal T cell graft in a patient with severe combined immunodeficiency (SCID). Transplantation 1983; 36:733-735.
46. Zhang L, Miller RG: The correlation of prolonged survival of maternal skin grafts with the presence of naturally transferred maternal T cells. Transplantation 1993; 56:918-921.
47. Piotrowski P, Croy BA: Maternal cells are widely distributed in murine fetuses in utero. Biol Reprod 1996; 54:1103- 1110.
48. Puri S, Shieh DC, Canavan A, Kao JK: Quantitation and characterisation of plasma HLA in neonates of different gestational ages. Tissue Antigens 1993; 42:67-71.
49. Adeniyi-Jones SC, Ozato K: Transfer of antibodies directed to paternal major histocompatibility class I antigens from pregnant mice to the developing fetus. J Immunol 1987; 138:1408-1415.
50. Johansen PM, Brown PJ: Fcy receptors in the human placenta. Placenta 1981; 2:355-370.
51. Longo LD, Hardesty JS: Maternal blood volume: measurement, hypothesis of control and clinical considerations. Rev Perinat Med 1984; 5:35-59.